Vetiqure AB is a wholly owned subsidiary of Scandinavian ChemoTech AB, a dynamic Life Science company that focus on developing technologies and therapies for various cancer tumours and advanced pain control for cancer. The Company has extensive experience in Tumour Specific Electroporation ™ (TSE), which forms the basis of the Company’s therapeutic areas. Currently, the Company is offering treatments for a various forms of cancer tumours. Our product, vetIQure ™ , is designed for animals based on a technology developed to treat humans. Its new technology, TSE, makes it possible to treat non-responsive tumours and tumours in sensitive locations.